{"id":871371,"date":"2025-08-05T19:18:02","date_gmt":"2025-08-05T23:18:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/"},"modified":"2025-08-05T19:18:02","modified_gmt":"2025-08-05T23:18:02","slug":"gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/","title":{"rendered":"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery"},"content":{"rendered":"

<\/p>\n

Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery<\/b><\/p>\n

Contact Award-Winning Firm, Gibbs Mura<\/b><\/p>\n

OAKLAND, Calif.–(BUSINESS WIRE<\/a>)–
\nGibbs Mura reminds investors that a class action lawsuit has been filed on behalf of investors who purchased or acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025, and June 23, 2025. Previously, shares of Hims & Hers Health, Inc. (\u201cHims & Hers\u201d) fell over 33% in intraday trading on Monday, June 23, 2025, after Novo Nordisk announced it was ending its collaboration with the telehealth company following concerns that it was engaging in \u201cdeceptive promotion and selling of illegitimate, knockoff versions of [weight loss drug] Wegovy that put patient safety at risk.\u201d Then, on August 5, 2025, Hims & Hers stock fell over 12% in intraday trading after the company released quarterly earnings and revenue that missed analysts\u2019 expectations.<\/p>\n

\nGibbs Mura encourages investors to contact us about their legal rights and options in the Hims & Hers Health, Inc. (NYSE: HIMS) Securities Class Action Lawsuit<\/a>.<\/p>\n

What Should Hims & Hers Investors Do?<\/b><\/p>\n

If you invested in HIMS, visit our <\/b>Hims & Hers Health, Inc. lawsuit webpage,<\/b><\/a> or call us at (888) 410-2925 <\/b>to get more information about how you may be able to recover your losses. Our investigation concerns whether Hims & Hers has violated federal securities laws by providing false or misleading statements to investors.<\/p>\n

What is the Hims & Hers Lawsuit About?<\/b><\/p>\n

\nOn June 23, 2025, Novo Nordisk announced it was terminating its collaboration with Hims & Hers following concerns that it was reportedly engaging in deceptive marketing practices and illegally promoting cheaper knock-off versions of the weight loss drug, Wegovy.<\/p>\n

\nIn April 2025, Novo Nordisk said it would offer Wegovy through a number of telehealth companies, including Hims & Hers, following the end of a Wegovy shortage. The end of this shortage \u201cmeant compounding pharmacies were legally restricted from making and selling cheaper, unapproved versions of the drug by May 22 \u2013 with rare exceptions,\u201d as reported by CNBC. Then, on Monday, June 23, 2025, Novo Nordisk issued a statement that it was terminating its relationship with Hims & Hers because the company \u201cfailed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of \u2018personalization,\u2019\u201d adding that the company is \u201cdisseminating deceptive marketing that put patient safety at risk.\u201d<\/p>\n

\nThe lawsuit alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements and specifically failed to disclose to investors that Hims & Hers was engaged in the \u201cdeceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk\u201d and \u201cas a result, there was a substantial risk that the Company\u2019s collaboration with Novo Nordisk would be terminated.\u201d<\/p>\n

About Gibbs Mura, A Law Group<\/b><\/p>\n

\nGibbs Mura represents investors nationwide in securities litigation<\/a>. The firm has recovered over a billion dollars for its clients against some of the world\u2019s largest corporations, and our attorneys have received numerous honors for their work, including \u201cBest Lawyers in America,\u201d \u201cTop Plaintiff Lawyers in California,\u201d \u201cCalifornia Lawyer Attorney of the Year,\u201d \u201cClass Action Practice Group of the Year,\u201d \u201cConsumer Protection MVP,\u201d and \u201cTop Women Lawyers in California.\u201d<\/p>\n

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/i><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250805972720\/en\/<\/a><\/span><\/p>\n

\nCONTACT: CATHERINE CONROY
\n
PHONE: 510.350.9705
\n
EMAIL: CRC@CLASSLAWGROUP.COM<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery Contact Award-Winning Firm, Gibbs Mura OAKLAND, Calif.–(BUSINESS WIRE)– Gibbs Mura reminds investors that a class action lawsuit has been filed on behalf of investors who purchased or acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025, and June 23, 2025. Previously, shares of Hims & Hers Health, Inc. (\u201cHims & Hers\u201d) fell over 33% in intraday trading on Monday, June 23, 2025, after Novo Nordisk announced it was ending its collaboration with the telehealth company following concerns that it was engaging in \u201cdeceptive promotion and selling of illegitimate, knockoff versions of [weight loss drug] Wegovy … <\/p>\n

Continue reading “Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-871371","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery Contact Award-Winning Firm, Gibbs Mura OAKLAND, Calif.–(BUSINESS WIRE)– Gibbs Mura reminds investors that a class action lawsuit has been filed on behalf of investors who purchased or acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025, and June 23, 2025. Previously, shares of Hims & Hers Health, Inc. (\u201cHims & Hers\u201d) fell over 33% in intraday trading on Monday, June 23, 2025, after Novo Nordisk announced it was ending its collaboration with the telehealth company following concerns that it was engaging in \u201cdeceptive promotion and selling of illegitimate, knockoff versions of [weight loss drug] Wegovy … Continue reading "Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-05T23:18:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery\",\"datePublished\":\"2025-08-05T23:18:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/\"},\"wordCount\":605,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/\",\"name\":\"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-08-05T23:18:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/","og_locale":"en_US","og_type":"article","og_title":"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery - Market Newsdesk","og_description":"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery Contact Award-Winning Firm, Gibbs Mura OAKLAND, Calif.–(BUSINESS WIRE)– Gibbs Mura reminds investors that a class action lawsuit has been filed on behalf of investors who purchased or acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025, and June 23, 2025. Previously, shares of Hims & Hers Health, Inc. (\u201cHims & Hers\u201d) fell over 33% in intraday trading on Monday, June 23, 2025, after Novo Nordisk announced it was ending its collaboration with the telehealth company following concerns that it was engaging in \u201cdeceptive promotion and selling of illegitimate, knockoff versions of [weight loss drug] Wegovy … Continue reading \"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-05T23:18:02+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery","datePublished":"2025-08-05T23:18:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/"},"wordCount":605,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/","name":"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-08-05T23:18:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250805972720r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gibbs-mura-reminds-hims-hers-health-inc-nyse-hims-investors-of-opportunity-to-join-a-class-action-lawsuit-seeking-recovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/871371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=871371"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/871371\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=871371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=871371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=871371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}